Search results
Results From The WOW.Com Content Network
The Macpherson-Grant family began looking for a use for old farm buildings on the grounds of Speyside's Ballindalloch Castle in late summer 2011, and they decided to build a distillery, but keeping the old buildings preserved as far as possible. [1] Ballindalloch distillery began production in September 2014. [2] [3]
John L.S. Grant, who joined Glenfarclas in 1973, is the current chairman. The company was named Distiller of the Year by Whisky Magazine in 2006, 2020 and 2023 . [3] Since 2006 Glenfarclas has been distributed in the UK by Pol Roger Ltd. [4] In 2008 the company began sponsoring horseracing with the Glenfarclas Cross Country Handicap Chase at
Ballindalloch (Scottish Gaelic: Baile na Dalach) is a small village on the River Spey in Scotland. It is known for its whisky distilleries and for Ballindalloch Castle. [1] [2] Until 1961 there was a station on the Great North of Scotland Railway. In Ballindalloch itself, there are two distilleries, Cragganmore distillery and Ballindalloch ...
In 1923, after Gordon death, his widow Mary Jane takes over and finally sells it to the Cragganmore-Glenlivet Distillery Co., which is owned equally by Peter Mackie from White Horse and Ballindalloch Estate. [3] Mackie sold his share to The Distillers Company but Macpherson-Grant family keeps its 50% ownership until 1965. [4]
Trenbolone hexahydrobenzylcarbonate, or trenbolone cyclohexylmethylcarbonate, sold under the brand names Parabolan and Hexabolan, is a synthetic, injected anabolic–androgenic steroid (AAS) of the nandrolone group and an androgen ester – specifically, the C17β hexahydrobenzylcarbonate (cyclohexylmethylcarbonate) ester of trenbolone – which was marketed in France for medical use in humans ...
Stilbestrol, or stilboestrol, also known as 4,4'-dihydroxystilbene or 4,4'-stilbenediol, is a stilbenoid nonsteroidal estrogen [1] and the parent compound of a group of more potent nonsteroidal estrogen derivatives that includes, most notably, diethylstilbestrol (DES).
Otilonium bromide is a drug used to treat abdominal pain caused by irritable bowel syndrome. It is an antispasmodic , which is useful to treat the symptoms of irritable bowel syndrome by reducing abdominal spasms ( colic ), bloating, pain, and gut motility.
Side effects of thiocolchicoside can include nausea, allergy and vasovagal reactions. [15] Liver injury, pancreatitis, seizures, blood cell disorders, severe cutaneous disorders, rhabdomyolysis, and reproductive disorders have all been recorded in the French and European pharmacovigilance databases and in the periodic updates that the companies concerned submit to regulatory agencies.